Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Botanix Pharmaceuticals Limited ( (AU:BOT) ) has issued an announcement.
Botanix Pharmaceuticals Limited announced a change in the director’s interest, with Dr. Stewart Washer exercising options to acquire 3,990,099 ordinary fully paid shares, while disposing of 5,000,000 unlisted options. This transaction was executed under the company’s Employee Awards Plan, reflecting a strategic move to align management interests with shareholder value, potentially impacting the company’s market perception and stakeholder confidence.
More about Botanix Pharmaceuticals Limited
Botanix Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the development of dermatology and antimicrobial products. The company is known for its innovative approaches in the treatment of skin diseases and infections, leveraging advanced drug delivery technologies.
YTD Price Performance: 7.95%
Average Trading Volume: 5,954,681
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$867.2M
For detailed information about BOT stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue